The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6
Expression of the cellular karyopherin TNPO3/transportin-SR2/Tnp3 is necessary for HIV-1 infection. Depletion of TNPO3 expression in mammalian cells inhibits HIV-1 infection after reverse transcription but prior to integration. This work explores the role of cleavage and polyadenylation specificity...
Gespeichert in:
Veröffentlicht in: | Retrovirology 2013-04, Vol.10 (1), p.46-46, Article 46 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 46 |
---|---|
container_issue | 1 |
container_start_page | 46 |
container_title | Retrovirology |
container_volume | 10 |
creator | Fricke, Thomas Valle-Casuso, Jose Carlos White, Tommy E Brandariz-Nuñez, Alberto Bosche, William J Reszka, Natalia Gorelick, Robert Diaz-Griffero, Felipe |
description | Expression of the cellular karyopherin TNPO3/transportin-SR2/Tnp3 is necessary for HIV-1 infection. Depletion of TNPO3 expression in mammalian cells inhibits HIV-1 infection after reverse transcription but prior to integration.
This work explores the role of cleavage and polyadenylation specificity factor subunit 6 (CPSF6) in the ability of TNPO3-depleted cells to inhibit HIV-1 infection. Our findings showed that depletion of TNPO3 expression inhibits HIV-1 infection, while the simultaneous depletion of TNPO3 and CPSF6 expression rescues HIV-1 infection. Several experiments to understand the rescue of infectivity by CPSF6 were performed. Our experiments revealed that the HIV-1 capsid binding ability of the endogenously expressed CPSF6 from TNPO3-depleted cells does not change when compared to CPSF6 from wild type cells. In agreement with our previous results, depletion of TNPO3 did not change the nuclear localization of CPSF6. Studies on the formation of 2-LRT circles during HIV-1 infection revealed that TNPO3-depleted cells are impaired in the integration process or exhibit a defect in the formation of 2-LTR circles. To understand whether the cytosolic fraction of CPSF6 is responsible for the inhibition of HIV-1 in TNPO3-depleted cells, we tested the ability of a cytosolic full-length CPSF6 to block HIV-1 infection. These results demonstrated that overexpression of a cytosolic full-length CPSF6 blocks HIV-1 infection at the nuclear import step. Fate of the capsid assays revealed that cytosolic expression of CPSF6 enhances stability of the HIV-1 core during infection.
These results suggested that inhibition of HIV-1 by TNPO3-depleted cells requires CPSF6. |
doi_str_mv | 10.1186/1742-4690-10-46 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3695788</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A534690453</galeid><sourcerecordid>A534690453</sourcerecordid><originalsourceid>FETCH-LOGICAL-b646t-1ac6cf1dc9f34395e962824fa37ae8f311885a38c70eb426a5962b86d13cdfbe3</originalsourceid><addsrcrecordid>eNqNUk1r3DAQFaWl-WjPvRVBL7040YctS5dCujRNIG0C3fYqZHmUVbCtjWQX8u8js-myW1IoOow08-bx5mkQekfJCaVSnNK6ZEUpFCkoyfEFOtxmXu7cD9BRSneEcCqJfI0OGBeM0bI6RN-WK8Cm8Z0fH3BwePn95poXLaw7GKHFFrou4TFgP6x840d8cfmroPnlwI4-DDjC_eQjJLy4-XEu3qBXznQJ3j7FY_Tz_MtycVFcXX-9XJxdFY0oxVhQY4V1tLXK8ZKrCpRgkpXO8NqAdDyPJivDpa0JNCUTpsqARoqWctu6Bvgx-rThXU9ND62FYYym0-voexMfdDBe71cGv9K34bfmQlW1lJng84ag8eEfBPsVG3o926lnOzUlOWaSj08qYrifII2692l2zAwQpqQpV0oxKjn7D2jNasLqepb24S_oXZjikO2cUXVZSbWLujUd6PwfIcu0M6k-q_gssqx4Rp08g8qnhd7bMIDzOb_XcLppsDGkFMFtLckjzxv3jAnvd79ii_-zYvwR7mfNsw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1377458978</pqid></control><display><type>article</type><title>The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>SpringerLink Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Fricke, Thomas ; Valle-Casuso, Jose Carlos ; White, Tommy E ; Brandariz-Nuñez, Alberto ; Bosche, William J ; Reszka, Natalia ; Gorelick, Robert ; Diaz-Griffero, Felipe</creator><creatorcontrib>Fricke, Thomas ; Valle-Casuso, Jose Carlos ; White, Tommy E ; Brandariz-Nuñez, Alberto ; Bosche, William J ; Reszka, Natalia ; Gorelick, Robert ; Diaz-Griffero, Felipe</creatorcontrib><description>Expression of the cellular karyopherin TNPO3/transportin-SR2/Tnp3 is necessary for HIV-1 infection. Depletion of TNPO3 expression in mammalian cells inhibits HIV-1 infection after reverse transcription but prior to integration.
This work explores the role of cleavage and polyadenylation specificity factor subunit 6 (CPSF6) in the ability of TNPO3-depleted cells to inhibit HIV-1 infection. Our findings showed that depletion of TNPO3 expression inhibits HIV-1 infection, while the simultaneous depletion of TNPO3 and CPSF6 expression rescues HIV-1 infection. Several experiments to understand the rescue of infectivity by CPSF6 were performed. Our experiments revealed that the HIV-1 capsid binding ability of the endogenously expressed CPSF6 from TNPO3-depleted cells does not change when compared to CPSF6 from wild type cells. In agreement with our previous results, depletion of TNPO3 did not change the nuclear localization of CPSF6. Studies on the formation of 2-LRT circles during HIV-1 infection revealed that TNPO3-depleted cells are impaired in the integration process or exhibit a defect in the formation of 2-LTR circles. To understand whether the cytosolic fraction of CPSF6 is responsible for the inhibition of HIV-1 in TNPO3-depleted cells, we tested the ability of a cytosolic full-length CPSF6 to block HIV-1 infection. These results demonstrated that overexpression of a cytosolic full-length CPSF6 blocks HIV-1 infection at the nuclear import step. Fate of the capsid assays revealed that cytosolic expression of CPSF6 enhances stability of the HIV-1 core during infection.
These results suggested that inhibition of HIV-1 by TNPO3-depleted cells requires CPSF6.</description><identifier>ISSN: 1742-4690</identifier><identifier>EISSN: 1742-4690</identifier><identifier>DOI: 10.1186/1742-4690-10-46</identifier><identifier>PMID: 23622145</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Analysis ; beta Karyopherins - metabolism ; Cancer ; Cell Line ; Cells ; Experiments ; Genetic aspects ; HIV-1 - immunology ; HIV-1 - physiology ; Human immunodeficiency virus 1 ; Humans ; Infections ; Medical research ; Medicine, Experimental ; mRNA Cleavage and Polyadenylation Factors - metabolism ; Proteins ; Reverse Transcription ; RNA splicing ; Virus Integration</subject><ispartof>Retrovirology, 2013-04, Vol.10 (1), p.46-46, Article 46</ispartof><rights>COPYRIGHT 2013 BioMed Central Ltd.</rights><rights>2013 Fricke et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2013 Fricke et al.; licensee BioMed Central Ltd. 2013 Fricke et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b646t-1ac6cf1dc9f34395e962824fa37ae8f311885a38c70eb426a5962b86d13cdfbe3</citedby><cites>FETCH-LOGICAL-b646t-1ac6cf1dc9f34395e962824fa37ae8f311885a38c70eb426a5962b86d13cdfbe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695788/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695788/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23622145$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fricke, Thomas</creatorcontrib><creatorcontrib>Valle-Casuso, Jose Carlos</creatorcontrib><creatorcontrib>White, Tommy E</creatorcontrib><creatorcontrib>Brandariz-Nuñez, Alberto</creatorcontrib><creatorcontrib>Bosche, William J</creatorcontrib><creatorcontrib>Reszka, Natalia</creatorcontrib><creatorcontrib>Gorelick, Robert</creatorcontrib><creatorcontrib>Diaz-Griffero, Felipe</creatorcontrib><title>The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6</title><title>Retrovirology</title><addtitle>Retrovirology</addtitle><description>Expression of the cellular karyopherin TNPO3/transportin-SR2/Tnp3 is necessary for HIV-1 infection. Depletion of TNPO3 expression in mammalian cells inhibits HIV-1 infection after reverse transcription but prior to integration.
This work explores the role of cleavage and polyadenylation specificity factor subunit 6 (CPSF6) in the ability of TNPO3-depleted cells to inhibit HIV-1 infection. Our findings showed that depletion of TNPO3 expression inhibits HIV-1 infection, while the simultaneous depletion of TNPO3 and CPSF6 expression rescues HIV-1 infection. Several experiments to understand the rescue of infectivity by CPSF6 were performed. Our experiments revealed that the HIV-1 capsid binding ability of the endogenously expressed CPSF6 from TNPO3-depleted cells does not change when compared to CPSF6 from wild type cells. In agreement with our previous results, depletion of TNPO3 did not change the nuclear localization of CPSF6. Studies on the formation of 2-LRT circles during HIV-1 infection revealed that TNPO3-depleted cells are impaired in the integration process or exhibit a defect in the formation of 2-LTR circles. To understand whether the cytosolic fraction of CPSF6 is responsible for the inhibition of HIV-1 in TNPO3-depleted cells, we tested the ability of a cytosolic full-length CPSF6 to block HIV-1 infection. These results demonstrated that overexpression of a cytosolic full-length CPSF6 blocks HIV-1 infection at the nuclear import step. Fate of the capsid assays revealed that cytosolic expression of CPSF6 enhances stability of the HIV-1 core during infection.
These results suggested that inhibition of HIV-1 by TNPO3-depleted cells requires CPSF6.</description><subject>Analysis</subject><subject>beta Karyopherins - metabolism</subject><subject>Cancer</subject><subject>Cell Line</subject><subject>Cells</subject><subject>Experiments</subject><subject>Genetic aspects</subject><subject>HIV-1 - immunology</subject><subject>HIV-1 - physiology</subject><subject>Human immunodeficiency virus 1</subject><subject>Humans</subject><subject>Infections</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>mRNA Cleavage and Polyadenylation Factors - metabolism</subject><subject>Proteins</subject><subject>Reverse Transcription</subject><subject>RNA splicing</subject><subject>Virus Integration</subject><issn>1742-4690</issn><issn>1742-4690</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNUk1r3DAQFaWl-WjPvRVBL7040YctS5dCujRNIG0C3fYqZHmUVbCtjWQX8u8js-myW1IoOow08-bx5mkQekfJCaVSnNK6ZEUpFCkoyfEFOtxmXu7cD9BRSneEcCqJfI0OGBeM0bI6RN-WK8Cm8Z0fH3BwePn95poXLaw7GKHFFrou4TFgP6x840d8cfmroPnlwI4-DDjC_eQjJLy4-XEu3qBXznQJ3j7FY_Tz_MtycVFcXX-9XJxdFY0oxVhQY4V1tLXK8ZKrCpRgkpXO8NqAdDyPJivDpa0JNCUTpsqARoqWctu6Bvgx-rThXU9ND62FYYym0-voexMfdDBe71cGv9K34bfmQlW1lJng84ag8eEfBPsVG3o926lnOzUlOWaSj08qYrifII2692l2zAwQpqQpV0oxKjn7D2jNasLqepb24S_oXZjikO2cUXVZSbWLujUd6PwfIcu0M6k-q_gssqx4Rp08g8qnhd7bMIDzOb_XcLppsDGkFMFtLckjzxv3jAnvd79ii_-zYvwR7mfNsw</recordid><startdate>20130426</startdate><enddate>20130426</enddate><creator>Fricke, Thomas</creator><creator>Valle-Casuso, Jose Carlos</creator><creator>White, Tommy E</creator><creator>Brandariz-Nuñez, Alberto</creator><creator>Bosche, William J</creator><creator>Reszka, Natalia</creator><creator>Gorelick, Robert</creator><creator>Diaz-Griffero, Felipe</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130426</creationdate><title>The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6</title><author>Fricke, Thomas ; Valle-Casuso, Jose Carlos ; White, Tommy E ; Brandariz-Nuñez, Alberto ; Bosche, William J ; Reszka, Natalia ; Gorelick, Robert ; Diaz-Griffero, Felipe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b646t-1ac6cf1dc9f34395e962824fa37ae8f311885a38c70eb426a5962b86d13cdfbe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Analysis</topic><topic>beta Karyopherins - metabolism</topic><topic>Cancer</topic><topic>Cell Line</topic><topic>Cells</topic><topic>Experiments</topic><topic>Genetic aspects</topic><topic>HIV-1 - immunology</topic><topic>HIV-1 - physiology</topic><topic>Human immunodeficiency virus 1</topic><topic>Humans</topic><topic>Infections</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>mRNA Cleavage and Polyadenylation Factors - metabolism</topic><topic>Proteins</topic><topic>Reverse Transcription</topic><topic>RNA splicing</topic><topic>Virus Integration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fricke, Thomas</creatorcontrib><creatorcontrib>Valle-Casuso, Jose Carlos</creatorcontrib><creatorcontrib>White, Tommy E</creatorcontrib><creatorcontrib>Brandariz-Nuñez, Alberto</creatorcontrib><creatorcontrib>Bosche, William J</creatorcontrib><creatorcontrib>Reszka, Natalia</creatorcontrib><creatorcontrib>Gorelick, Robert</creatorcontrib><creatorcontrib>Diaz-Griffero, Felipe</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Retrovirology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fricke, Thomas</au><au>Valle-Casuso, Jose Carlos</au><au>White, Tommy E</au><au>Brandariz-Nuñez, Alberto</au><au>Bosche, William J</au><au>Reszka, Natalia</au><au>Gorelick, Robert</au><au>Diaz-Griffero, Felipe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6</atitle><jtitle>Retrovirology</jtitle><addtitle>Retrovirology</addtitle><date>2013-04-26</date><risdate>2013</risdate><volume>10</volume><issue>1</issue><spage>46</spage><epage>46</epage><pages>46-46</pages><artnum>46</artnum><issn>1742-4690</issn><eissn>1742-4690</eissn><abstract>Expression of the cellular karyopherin TNPO3/transportin-SR2/Tnp3 is necessary for HIV-1 infection. Depletion of TNPO3 expression in mammalian cells inhibits HIV-1 infection after reverse transcription but prior to integration.
This work explores the role of cleavage and polyadenylation specificity factor subunit 6 (CPSF6) in the ability of TNPO3-depleted cells to inhibit HIV-1 infection. Our findings showed that depletion of TNPO3 expression inhibits HIV-1 infection, while the simultaneous depletion of TNPO3 and CPSF6 expression rescues HIV-1 infection. Several experiments to understand the rescue of infectivity by CPSF6 were performed. Our experiments revealed that the HIV-1 capsid binding ability of the endogenously expressed CPSF6 from TNPO3-depleted cells does not change when compared to CPSF6 from wild type cells. In agreement with our previous results, depletion of TNPO3 did not change the nuclear localization of CPSF6. Studies on the formation of 2-LRT circles during HIV-1 infection revealed that TNPO3-depleted cells are impaired in the integration process or exhibit a defect in the formation of 2-LTR circles. To understand whether the cytosolic fraction of CPSF6 is responsible for the inhibition of HIV-1 in TNPO3-depleted cells, we tested the ability of a cytosolic full-length CPSF6 to block HIV-1 infection. These results demonstrated that overexpression of a cytosolic full-length CPSF6 blocks HIV-1 infection at the nuclear import step. Fate of the capsid assays revealed that cytosolic expression of CPSF6 enhances stability of the HIV-1 core during infection.
These results suggested that inhibition of HIV-1 by TNPO3-depleted cells requires CPSF6.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>23622145</pmid><doi>10.1186/1742-4690-10-46</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1742-4690 |
ispartof | Retrovirology, 2013-04, Vol.10 (1), p.46-46, Article 46 |
issn | 1742-4690 1742-4690 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3695788 |
source | MEDLINE; DOAJ Directory of Open Access Journals; SpringerLink Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access; Springer Nature OA Free Journals |
subjects | Analysis beta Karyopherins - metabolism Cancer Cell Line Cells Experiments Genetic aspects HIV-1 - immunology HIV-1 - physiology Human immunodeficiency virus 1 Humans Infections Medical research Medicine, Experimental mRNA Cleavage and Polyadenylation Factors - metabolism Proteins Reverse Transcription RNA splicing Virus Integration |
title | The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T05%3A42%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20ability%20of%20TNPO3-depleted%20cells%20to%20inhibit%20HIV-1%20infection%20requires%20CPSF6&rft.jtitle=Retrovirology&rft.au=Fricke,%20Thomas&rft.date=2013-04-26&rft.volume=10&rft.issue=1&rft.spage=46&rft.epage=46&rft.pages=46-46&rft.artnum=46&rft.issn=1742-4690&rft.eissn=1742-4690&rft_id=info:doi/10.1186/1742-4690-10-46&rft_dat=%3Cgale_pubme%3EA534690453%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1377458978&rft_id=info:pmid/23622145&rft_galeid=A534690453&rfr_iscdi=true |